Is there a role for academia in drug discovery [electronic resource] / Adrian J. Ivinson.

By: Ivinson, Adrian J [spk]Material type: FilmFilmSeries: Henry Stewart talksBiomedical & life sciences collection. Drug discovery and development in the neurosciences: ; Henry Stewart talksBiomedical & life sciences collection. Small molecule drug discovery: Publisher: London : Henry Stewart Talks, 2013Description: 1 online resource (1 streaming video file (55 min.) : color, sound)Subject(s): Drug development | Drugs -- Research | Neurology -- Research | Pharmaceutical industry | Academic Medical Centers | Drug Design | Drug Discovery | Drug Industry -- organization & administration | Interinstitutional Relations | Neurodegenerative Diseases -- drug therapy | Pharmaceutical Preparations -- economics | Research -- economicsOnline resources: Click here to access online | Series (Drug discovery and development in the neurosciences) | Series (Small molecule drug discovery)
Contents:
Contents: Increasing numbers of neurological disorders correlates with the growing numbers of elderly -- Paucity of drugs that treat these neurological disorders -- Reasons for this failure -- Need to reassess the traditional division of labor between the for-profit sector and the not-for-profit academic sector -- Transfer of the discovery phase to academia? -- Other aspects of the heretofore-failed neuro drug discovery pipeline e.g. large-scale genetic studies aimed at unearthing new targets -- The need to redefine the precompetitive space -- The need to build new collaborations between companies, and between the commercial and academic sectors.
Tags from this library: No tags from this library for this title. Log in to add tags.
    Average rating: 0.0 (0 votes)
No physical items for this record

Animated audio-visual presentation with synchronized narration.

Title from title frames.

Contents: Increasing numbers of neurological disorders correlates with the growing numbers of elderly -- Paucity of drugs that treat these neurological disorders -- Reasons for this failure -- Need to reassess the traditional division of labor between the for-profit sector and the not-for-profit academic sector -- Transfer of the discovery phase to academia? -- Other aspects of the heretofore-failed neuro drug discovery pipeline e.g. large-scale genetic studies aimed at unearthing new targets -- The need to redefine the precompetitive space -- The need to build new collaborations between companies, and between the commercial and academic sectors.

Access restricted to subscribers.

Mode of access: World Wide Web.

Technical University of Mombasa
Tom Mboya Street, Tudor 90420-80100 , Mombasa Kenya
Tel: (254)41-2492222/3 Fax: 2490571